UNSPSC 51302323: Oxiconazole

This classification denotes an antifungal agent with the molecular formula C18H13Cl4N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C668Q9I33J, chemically known as 1h-imidazole, 1-(2-((2-chloro-3-thienyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)- but generally known as oxiconazole, which bears US NIH Compound Identifier 5482. European Medicines Agency schedules Oxiconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09523MIG.

UNSPSC 51302323 Oxiconazole, a Commodity code, shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code is catalogued as an antifungal pharmaceutical active ingredient, yet the two most recent opportunities posted under it concern liquid aluminum sulfate for wastewater treatment and medical first aid supplies—neither directly related to oxiconazole products. State and local procurement offices appear to have tagged these opportunities with the oxiconazole code in error or as a placeholder, rendering the code unreliable for tracking actual pharmaceutical purchasing in this category.

The City of Austin issued IFB 2200 CSH1061 on July 27, 2026, requesting unpackaged liquid aluminum sulfate at 47–49% concentration (estimated annual quantity 179,200 gallons) for phosphorus removal at Austin Water's wastewater treatment facility, with bids due August 25, 2026; the City of Tampa Fire Rescue Department posted ITB 25-P-00157 on April 24, 2026, for 32 medical and first aid supply line items including antiseptic sprays, hydrogen peroxide, aspirin, bandages, and emergency blankets, with a total departmental budget of $100,000 and a bid opening originally scheduled for April 9, 2025. Neither solicitation reflects the code's oxiconazole designation. Practitioners should treat this code as showing little relevant recent activity for pharmaceutical purchasing and verify the actual UNSPSC classification for antifungal or other pharmaceutical solicitations through direct contact with procurement offices or recent bid notices in target geographies rather than rely on this code's current tagging.